PHAXIAM Therapeutics S.A. (PHXM.PA)

EUR 1.73

(-0.57%)

Net Debt Summary of PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.'s latest annual net debt in 2023 was -275 Thousand EUR , up 111.05% from previous year.
PHAXIAM Therapeutics S.A.'s latest quarterly net debt in 2024 Q2 was 9.4 Million EUR , down 0.0% from previous quarter.
PHAXIAM Therapeutics S.A. reported annual net debt of -25.26 Million EUR in 2022, down -85.16% from previous year.
PHAXIAM Therapeutics S.A. reported annual net debt of -13.64 Million EUR in 2021, up 19.9% from previous year.
PHAXIAM Therapeutics S.A. reported quarterly net debt of 9.4 Million EUR for 2024 Q2, down 0.0% from previous quarter.
PHAXIAM Therapeutics S.A. reported quarterly net debt of -275 Thousand EUR for 2023 Q4, down -101.09% from previous quarter.

Annual Net Debt Chart of PHAXIAM Therapeutics S.A. (2023 - 2016)

Historical Annual Net Debt of PHAXIAM Therapeutics S.A. (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	-275 Thousand EUR	111.05%
2022	-25.26 Million EUR	-85.16%
2021	-13.64 Million EUR	19.9%
2020	-17.03 Million EUR	71.17%
2019	-59.08 Million EUR	55.36%
2018	-132.35 Million EUR	22.91%
2017	-171.68 Million EUR	-393.62%
2016	-34.78 Million EUR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	- EUR	100.0%
2024 Q2	9.4 Million EUR	0.0%
2023 Q4	-275 Thousand EUR	-101.09%
2023 Q3	25.18 Million EUR	350.66%
2023 Q2	-10.04 Million EUR	7.61%
2023 FY	2.79 Million EUR	111.05%
2023 Q1	-10.87 Million EUR	56.94%
2022 Q2	-30.79 Million EUR	0.0%
2022 Q3	54.04 Million EUR	275.5%
2022 Q4	-25.26 Million EUR	-146.74%
2021 Q2	-21.09 Million EUR	0.0%
2021 Q4	-13.64 Million EUR	0.0%
2020 Q4	-17.03 Million EUR	0.0%
2020 Q2	-28.95 Million EUR	0.0%
2019 Q4	-59.08 Million EUR	0.0%

Peer Net Debt Comparison of PHAXIAM Therapeutics S.A.

Name	Net Debt	Net Debt Difference
Nicox S.A.	13.89 Million EUR	101.979%
European Medical Solutions	13.93 Million EUR	101.974%
FERMENTALG	4.19 Million EUR	106.559%